TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Hsp90 is one of the most conserved molecular chaperones ubiquitously expressed in normal cells and over-expressed in cancer cells. A pool of Hsp90 was found in cancer mitochondria and the expression of the mitochondrial Hsp90 homolog,TRAP1, was also elevated in many cancers. The mitochondrial pool of chaperones plays important roles in regulating mitochondrial integrity, protecting against oxidative stress, and inhibiting cell death. Pharmacological inactivation of the chaperones induced mitochondrial dysfunction and concomitant cell death selectively in cancer cells, suggesting they can be target proteins for the development of cancer therapeutics. Several drug candidates targeting TRAP1 and Hsp90 in the mitochondria have been developed and have shown strong cytotoxic activity in many cancers, but not in normal cells in vitro and in vivo. In this review, recent developments in the study of mitochondrial chaperones and the mitochondria-targeted chaperone inhibitors are discussed [BMB reports 2012; 45(1):1-6]
Abstract
Hsp90 is one of the most conserved molecular chaperones ubiquitously expressed in normal cells and over-expressed in cancer cells. A pool of Hsp90 was found in cancer mitochondria and the expression of the mitochondrial Hsp90 homolog,TRAP1, was also elevated in many cancers. The mitochondrial pool of chaperones plays important roles in regulating mitochondrial integrity, protecting against oxidative stress, and inhibiting cell death. Pharmacological inactivation of the chaperones induced mitochondrial dysfunction and concomitant cell death selectively in cancer cells, suggesting they can be target proteins for the development of cancer therapeutics. Several drug candidates targeting TRAP1 and Hsp90 in the mitochondria have been developed and have shown strong cytotoxic activity in many cancers, but not in normal cells in vitro and in vivo. In this review, recent developments in the study of mitochondrial chaperones and the mitochondria-targeted chaperone inhibitors are discussed [BMB reports 2012; 45(1):1-6]
참고문헌 (51)
- Welch, W. J., "The role of heat-shock proteins as molecular chaperones", Curr. Opin. Cell. Biol., 3, pp.1033~1038 (1991)
- Hightower, L. E., "Heat shock, stress proteins, chaperones, and proteotoxicity", Cell, 66, pp.191~197 (1991)
- Whitesell, L., "HSP90 and the chaperoning of cancer", Nat. Rev. Cancer, 5, pp.761~772 (2005)
- Pearl, L. H., "Structure and mechanism of the Hsp90 molecular chaperone machinery", Annu. Rev. Biochem, 75, pp.271~294 (2006)
- Feder, M. E, "Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology", Annu. Rev. Physiol., 61, pp.243~282 (1999)
- Taipale, M., "HSP90 at the hub of protein homeostasis: emerging mechanistic insights", Nat. Rev. Mol. Cell. Biol., 11, pp.515~528 (2010)
- Bagatell, R., "Altered Hsp90 function in cancer: a unique therapeutic opportunity", Mol. Cancer Ther., 3, pp.1021~1030 (2004)
- Blagg, B. S., "Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation", Med. Res. Rev., 26, pp.310~338 (2006)
- Solit, D. B., "Development and application of Hsp90 inhibitors", Drug Discov. Today, 13, pp.38~43 (2008)
- Biamonte, M. A., "Heat shock protein 90: inhibitors in clinical trials", J. Med. Chem., 53, pp.3~17 (2010)
- Chen, B., "The HSP90 family of genes in the human genome: insights into their divergence and evolution", Genomics, 86, pp.627~637 (2005)
- Song, H. Y., "Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor", J. Biol. Chem., 270, pp.3574~3581 (1995)
- Chen, C. F., "A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock", Mol. Cell. Biol., 16, pp.4691~4699 (1996)
- Felts, S. J., "The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties", J. Biol. Chem., 275, pp.3305~3312 (2000)
- Leskovar, A., "The ATPase cycle of the mitochondrial Hsp90 analog Trap1", J. Biol. Chem., 283, pp.11677~11688 (2008)
- Kang, B. H., "Regulation of tumor cell mitochondrial Homeostasis by an organelle-specific Hsp90 chaperone network", CELL, 131(2), pp.257~270 (2007), CELL PRESS
- Kang, B. H., "Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90", JOURNAL OF CLINICAL INVESTIGATION, 119(3), pp.454~464 (2009), AMER SOC CLINICAL INVESTIGATION INC
- Schleiff, E., "Common ground for protein translocation: access control for mitochondria and chloroplasts", Nat. Rev. Mol. Cell. Biol., 12, pp.48~59 (2011)
- Simmons, A. D., "A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses", Hum. Mol. Genet., 8, pp.2155~2164 (1999)
- Deocaris, C. C., "On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60", Cell Stress Chaperones, 11, pp.116~128 (2006)
- Patten, D. A., "Reactive oxygen species: stuck in the middle ofneurodegeneration", J. Alzheimers Dis., 20(Suppl 2), pp.S357~S367 (2010)
- Sotgia, F., "Mitochondrial oxidative stress drives tumor progressionand metastasis: should we use antioxidants as akey component of cancer treatment and prevention?", BMCMed., 9, pp.62~ (2011)
- Masuda, Y., "Involvement of tumor necrosis factor receptor- associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin", J. Biol. Chem., 279, pp.42503~42515 (2004)
- Montesano Gesualdi, N., "Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis", Stress, 10, pp.342~350 (2007)
- Hua, G., "Heat shock protein75 (TRAP1) antagonizes reactive oxygen species generationand protects cells from granzyme M-mediatedapoptosis", J. Biol. Chem., 282, pp.20553~20560 (2007)
- Im, C. N., "Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species", JOURNAL OF CELLULAR BIOCHEMISTRY, 100, pp.474~486 (2007), WILEY-LISS
- Siegelin, M. D., "Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells", J. Clin. Invest., 121, pp.1349~1360 (2011)
- Mattson, M. P., "Mitochondria in cell death: novel targets for neuroprotection and cardioprotection", Trends Mol. Med., 9, pp.196~205 (2003)
- Kroemer, G., "Mitochondrial membrane permeabilization in cell death", Physiol. Rev., 87, pp.99~163 (2007)
- Tsujimoto, Y., "Mitochondrial membrane permeability transition and cell death", Biochim. Biophys. Acta., 1757, pp.1297~1300 (2006)
- Baines, C. P., "Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death", Nat. Cell. Biol., 9, pp.550~555 (2007)
- Kokoszka, J. E., "The ADP", ATP translocator is not essential for the mitochondrial permeability transition pore, 2004, pp.427, 461~465
- Basso, E., "Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D", J. Biol. Chem., 280, pp.18558~18561 (2005)
- Baines, C. P., "Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death", Nature, 434, pp.658~662 (2005)
- Nakagawa, T., "Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death", Nature, 434, pp.652~658 (2005)
- Johnson, N., "Import and processing of heart mitochondrial cyclophilin D", Eur. J. Biochem., 263, pp.353~359 (1999)
- Kang, B. H. and Altieri, D. C., "Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones", ONCOGENE, 28(42), pp.3681~3688 (2009), NATURE PUBLISHING GROUP
- Coller, H. A., "Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion", Proc. Natl. Acad. Sci. U.S.A., 97, pp.3260~3265 (2000)
- Putz, S. M., "Malignant transformation in a defined geneticbackground: proteome changes displayed by 2D-PAGE", Mol. Cancer, 9, pp.254~ (2010)
- Leav, I., "Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer", Am. J. Pathol., 176, pp.393~401 (2010)
- Kang, B. H., "Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein", J. Biol. Chem., 286, pp.16758~16767 (2011)
- Pridgeon, J. W., "PINK1 protects against oxidative stress by phosphorylatingmitochondrial chaperone TRAP1", PLoS Biol., 5, pp.e172~ (2007)
- Trepel, J., "Targeting the dynamic HSP90 complex in cancer", Nat. Rev. Cancer, 10, pp.537~549 (2010)
- Gatenby, R. A., "Why do cancers have high aerobic glycolysis?", Nat. Rev. Cancer, 4, pp.891~899 (2004)
- Costantino, E., "TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptosis in human colorectal carcinoma cells", Cancer Lett., 279, pp.39~46 (2009)
- Liu, D., "Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases", Cancer Lett., 296, pp.194~205 (2010)
- Takemoto, K., "Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum", Neurochem. Int., 58, pp.880~887 (2011)
- Kang, B. H., "Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer", Clin. Cancer Res., 16, pp.4779~4788 (2010)
- Kang, B. H., "Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease", Br. J. Cancer, 104, pp.629~634 (2011)
- Plescia, J., "Rational design of shepherdin, a novel anticancer agent", Cancer Cell, 7, pp.457~468 (2005)
- Fulda, S., "Targeting mitochondria for cancer therapy", Nat. Rev. Drug Discov., 9, pp.447~464 (2010)
